About Avery Therapeutics
Avery Therapeutics is a private company based in Tucson, Arizona. It has reported $8,968,859 raised in two offerings on Form D since June 2017. Its chief executive is Jordan Lancaster.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Sep 21, 2026 | $8,468,859of $15.4M target | 23 | $368K | EquityRule 506(b) | Form D ↗ |
| May 12, 2017 | Jun 1, 2017 | $500,000of $1.5M target | 16 | $31,250 | DebtRule 506(b) | Form D ↗ |
| Total, two offerings | $8,968,859 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avery Therapeutics's Form D filed Sep 21, 2026.
Earlier filings also listed Jennifer Koevary (executive officer, last listed Jun 2017).